乳腺癌
医学
癌症
病理
外科病理学
肿瘤科
腋窝淋巴结
生物标志物
内科学
生物
生物化学
作者
Y P Liu,W T Yang,Hong Bu
出处
期刊:PubMed
日期:2023-09-08
卷期号:52 (9): 885-890
标识
DOI:10.3760/cma.j.cn112151-20230727-00030
摘要
Accurate pathology diagnosis of breast cancer is the premise of personalized treatment. In recent years, the pathology diagnosis of breast cancer have been updated and optimized to provide better guidance and basis for clinical treatment. In this paper, we provide an overview on the advances in histological classification of breast cancer, the progress of biomarker detection related to novel antibody-drug conjugates and immunotherapy in breast cancer, the pathology evaluation of breast cancer specimen after neoadjuvant therapy and sentinel lymph nodes, the progress of genetic testing in breast cancer, and the application of artificial intelligence in breast pathology.乳腺癌病理精准诊断是实现个体化治疗的前提。近年来,乳腺癌病理诊断规范不断更新和优化,为临床治疗提供更好的指导和依据。本文就乳腺癌组织学分型研究进展、乳腺癌相关新型抗体耦联药物及免疫治疗生物标志物的检测进展、新辅助治疗后及前哨淋巴结病理评估、乳腺癌的基因检测进展和人工智能辅助乳腺癌病理实践等内容展开论述。.
科研通智能强力驱动
Strongly Powered by AbleSci AI